Abstract

BackgroundVascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. However, a growing body of evidence indicates that VEGF also acts on non-vascular cells, both developmentally as well as in the adult. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical.Methods and FindingsUsing immunohistochemistry and Lac-Z reporter mouse lines, we report that VEGF is produced by various cells in the adult mouse retina and that VEGFR2, the primary signaling receptor, is also widely expressed, with strong expression by Müller cells and photoreceptors. Systemic neutralization of VEGF was accomplished in mice by adenoviral expression of sFlt1. After 14 days of VEGF neutralization, there was no effect on the inner and outer retina vasculature, but a significant increase in apoptosis of cells in the inner and outer nuclear layers. By four weeks, the increase in neural cell death was associated with reduced thickness of the inner and outer nuclear layers and a decline in retinal function as measured by electroretinograms. siRNA-based suppression of VEGF expression in a Müller cell line in vitro supports the existence of an autocrine role for VEGF in Müller cell survival. Similarly, the addition of exogenous VEGF to freshly isolated photoreceptor cells and outer-nuclear-layer explants demonstrated VEGF to be highly neuroprotective.ConclusionsThese results indicate an important role for endogenous VEGF in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution.

Highlights

  • The retina is one of the body’s most metabolically demanding tissues

  • These results indicate an important role for endogenous Vascular endothelial growth factor (VEGF) in the maintenance and function of adult retina neuronal cells and indicate that anti-VEGF therapies should be administered with caution

  • VEGF and VEGF receptor 2 (VEGFR2) expression in adult retina We have previously shown that VEGF is expressed by embryonic and adult retinal pigment epithelial cells (RPE) [3]

Read more

Summary

Introduction

To ensure adequate nutrient and oxygen delivery, the retina is supplied by two independent vascular beds, the inner retinal vasculature and outer choroidal circulation. These vascular beds have distinct morphologic properties; the inner retinal vasculature is the site of a blood-tissue barrier and is characterized by highly impermeable vessels, whereas the choriocapillaris consists of a highly fenestrated capillary plexus. Vascular endothelial growth factor (VEGF) is expressed by astrocytes in the retinal ganglion cell layer (GCL), by cells of inner nuclear layer (INL), Muller cells, and retinal pigment epithelial cells (RPE) [2,3]. Vascular endothelial growth factor (VEGF) is well known for its role in normal and pathologic neovascularization. In light of the widespread use of systemic and intraocular anti-VEGF therapies for the treatment of angiogenesis associated with tumor growth and wet macular degeneration, systematic investigation of the role of VEGF in the adult retina is critical

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call